Your browser doesn't support javascript.
loading
BRCA2 reversion mutation confers resistance to olaparib in breast cancer.
Yamamoto, Shinya; Kawashima, Kei; Fujiwara, Yoshie; Adachi, Shoko; Narui, Kazutaka; Hosaka, Chiaki; Takahashi, Rina; Tsuyuki, Sho; Sugimori, Makoto; Tanoshima, Miki; Sasamoto, Mahato; Oshi, Masanori; Yamada, Akimitsu; Kunisaki, Chikara; Endo, Itaru.
Afiliação
  • Yamamoto S; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
  • Kawashima K; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
  • Fujiwara Y; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
  • Adachi S; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
  • Narui K; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
  • Hosaka C; Department of Clinical Genetics Yokohama City University Medical Center Yokohama Japan.
  • Takahashi R; Department of Clinical Genetics Yokohama City University Medical Center Yokohama Japan.
  • Tsuyuki S; Department of Cancer Genome Medicine Yokohama City University Medical Center Yokohama Japan.
  • Sugimori M; Department of Cancer Genome Medicine Yokohama City University Medical Center Yokohama Japan.
  • Tanoshima M; Department of Clinical Genetics Yokohama City University Medical Center Yokohama Japan.
  • Sasamoto M; Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
  • Oshi M; Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
  • Yamada A; Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
  • Kunisaki C; Department of Cancer Genome Medicine Yokohama City University Medical Center Yokohama Japan.
  • Endo I; Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Clin Case Rep ; 11(6): e7537, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37361653

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article